Literature DB >> 70687

Circulating thymic-hormone activity in congenital immunodeficiency.

V Lewis, J J Twomey, G Goldstein, R O'Reilly, E Smithwick, R Pahwa, S Pahwa, R A Good, H Schulte-Wisserman, S Horowitz, R Hong, J Jones, O Sieber, C Kirkpatrick, S Polmar, P Bealmear.   

Abstract

Circulating thymic-hormone activity was assayed by measuring Thy 1-2 antigen induction on null lymphocytes from athymic mice incubated with human plasma or serum. Plasma from 19 normal children aged under 10 had inductive activity equivalent to 10-6-16-2 ng thymopoitin/ml. Plasma from 15 infants were severe combined immuno-deficiency, 2 of whom had appreciable immunoglobulin synthesis, and from 2 infants with DiGeorge syndrome had little or no inductive activity. Successful reconstitution with thymus or bone-marrow grafts and with red-cell infusions (if adenosine-deaminase deficiency is present) was followed by a rise in circulating thymic-hormone activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70687     DOI: 10.1016/s0140-6736(77)91601-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  9 in total

1.  Serum thymic hormone activity in protein-energy malnutrition.

Authors:  R K Chandra
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

2.  Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects.

Authors:  M Tas; J A Leezenberg; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

3.  Plasma thymic hormone activity in patients with chronic mucocutaneous candidiasis.

Authors:  C H Kirkpatrick; L E Greenberg; S W Chapman; G Goldstein; V M Lewis; J J Twomey
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

4.  T-lymphocyte differentiation in vitro in severe combined immunodeficiency. Defects of stem cells.

Authors:  R N Pahwa; S G Pahwa; R A Good
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

Review 5.  Cellular and molecular basis of immunodeficiencies: their consequences for the development and induction of the immune response.

Authors:  J Sterzl
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

6.  Steroid economising effects of a calf thymus extract in three patients with juvenile chronic arthritis.

Authors:  W Pernice; R Stahn; H A Fabricius; R Klingshirn
Journal:  Klin Wochenschr       Date:  1983-04-15

Review 7.  Thymopoietin to thymopentin: experimental studies.

Authors:  G Goldstein; T K Audhya
Journal:  Surv Immunol Res       Date:  1985

Review 8.  Thymopentin and splenopentin as immunomodulators. Current status.

Authors:  V K Singh; S Biswas; K B Mathur; W Haq; S K Garg; S S Agarwal
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

9.  Transplantation of cultured thymic fragments. II. Results in nude mice.

Authors:  R Hong; H Schulte-Wissermann; E Jarrett-Toth; S D Horowitz; D D Manning
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.